Capital Research Global Investors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.3M Buy
+3,593,576
New +$72.2M 0.01% 341
2022
Q1
Sell
-900,000
Closed -$12.7M 441
2021
Q4
$12.7M Sell
900,000
-489,096
-35% -$8.57M ﹤0.01% 419
2021
Q3
$22.2M Sell
1,389,096
-360,904
-21% -$6.97M 0.01% 408
2021
Q2
$40.9M Hold
1,750,000
0.01% 382
2021
Q1
$38.4M Buy
+1,750,000
New +$34.2M 0.01% 376

Other funds holding ALHC

Capital Research Global Investors's ALHC Position: Q1 2026 in Review

Capital Research Global Investors opened a new position in Alignment Healthcare (ALHC) in Q1 2026: 3,593,576 shares worth $63.3M. The stake represents 0.01% of the portfolio and ranks #341 among its holdings. This is a return to the name: Capital Research Global Investors previously reported a position in ALHC as recently as Q4 2021.

Capital Research Global Investors first reported a position in ALHC in Q1 2021 and has held it in 5 quarters since. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Capital Research Global Investors held 3,593,576 shares of Alignment Healthcare worth $63.3M as of Q1 2026.
  • Alignment Healthcare was a new Capital Research Global Investors position in Q1 2026.
  • Alignment Healthcare made up 0.01% of Capital Research Global Investors's portfolio in Q1 2026, its #341 holding.
  • Capital Research Global Investors first reported a position in Alignment Healthcare in Q1 2021 and has held it in 5 quarters since.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.